Polaris Group
Records under this name other than the patents Polaris Group holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 10 patents it holds.
Showing 1 to 8 of 8 · Back to Polaris Group
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,204,980 | Methods for Inhibiting Viral Replication in Vivo Term ended Term ended Sep 29, 2023 · High confidence | Term ended | Term ended Sep 29, 2023 | High confidence |
| US 6,913,915 | Peg-Modified Uricase Formerly held Term ended Term ended Aug 2, 2021 · High confidence | Term ended | Term ended Aug 2, 2021 | High confidence |
| US 6,645,739 | Yeast Expression Systems, Methods of Producing Polypeptides in Yeast, and Compositions Relating to Same Term ended Term ended Jul 26, 2021 · High confidence | Term ended | Term ended Jul 26, 2021 | High confidence |
| US 7,517,882 | Protein kinase inhibitors Lapsed on the fee record Ended Apr 14, 2021 · From the USPTO record | Lapsed on the fee record | Ended Apr 14, 2021 | From the USPTO record |
| US 7,323,167 | Method of treatment with modified arginine deiminase Term ended Term ended Mar 24, 2019 · From the USPTO record | Term ended | Term ended Mar 24, 2019 | From the USPTO record |
| US 7,785,579 | Modified tumor necrosis factor Term ended Term ended Apr 22, 2018 · From the USPTO record | Term ended | Term ended Apr 22, 2018 | From the USPTO record |
| US 6,635,462 | Mutated form of arginine deiminase Term ended Term ended Feb 13, 2018 · From the USPTO record | Term ended | Term ended Feb 13, 2018 | From the USPTO record |
| US 6,737,259 | Modified arginine deiminase Term ended Ended no later than Feb 13, 2018 · From the USPTO record | Term ended | Ended no later than Feb 13, 2018 | From the USPTO record |